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Abstract
Background—Effects of traffic-related exposures on respiratory health are well documented, 
but little information is available about whether asthma control influences individual 
susceptibility. We analyzed data from the Atlanta Commuter Exposure study to evaluate 
modification of associations between rush-hour commuting, in-vehicle air pollution, and selected 
respiratory health outcomes by asthma control status.
Methods—Between 2009 and 2011, 39 adults participated in Atlanta Commuter Exposure, and 
each conducted two scripted rush-hour highway commutes. In-vehicle particulate components 
were measured during all commutes. Among adults with asthma, we evaluated asthma control by 
questionnaire and spirometry. Exhaled nitric oxide, forced expiratory volume in 1 second (FEV1), 
and other metrics of respiratory health were measured precommute and 0, 1, 2, and 3 hours 
postcommute. We used mixed effects linear regression to evaluate associations between commute-
related exposures and postcommute changes in metrics of respiratory health by level of asthma 
control.
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Results—We observed increased exhaled nitric oxide across all levels of asthma control 
compared with precommute measurements, with largest postcommute increases observed among 
participants with below-median asthma control (2 hours postcommute: 14.6% [95% confidence 
interval {CI} = 5.7, 24.2]; 3 hours postcommute: 19.5% [95% CI = 7.8, 32.5]). No associations 
between in-vehicle pollutants and percent of predicted FEV1 were observed, although higher 
PM2.5 was associated with lower FEV1 % predicted among participants with below-median 
asthma control (3 hours postcommute: −7.2 [95% CI = −11.8, −2.7]).
Conclusions—Level of asthma control may influence respiratory response to in-vehicle 
exposures experienced during rush-hour commuting.
Individuals who commute by car are exposed to a mixture of exposures that includes 
particulate and gaseous pollutants, noise, and stress.1 In-vehicle measurements of organic 
and inorganic particulate matter components indicate that drivers and passengers are 
exposed to exhaust, regardless of whether they use vehicle air filters or drive with the 
windows closed.2 The effects of traffic-related air pollution on respiratory health, including 
on respiratory health of individuals with asthma, are well documented.3-5 However, little 
information is available about the contribution of asthma to individual susceptibility or 
whether any such susceptibility may be affected by level of asthma control.
The Atlanta Commuter Exposure (ACE-1) pilot study was initiated in 2009 to evaluate 
associations between in-vehicle air pollutant mixtures and cardiorespiratory health responses 
among rush-hour automobile commuters. Recent findings from the ACE-1 study suggest 
that a 2-hour commute during morning rush-hour traffic is associated with increased 
pulmonary inflammation and reduced measures of heart-rate variability.6 Increased 
concentrations of exhaled nitric oxide (NO) observed postcommute suggest that traffic-
related exposures may lead to short-term inflammation in the lung. Variation in the 
magnitude of the responses among individuals with asthma may reflect differences in 
asthma phenotype or level of asthma control.6 The ACE-1 study provides a unique 
opportunity to further investigate the extent to which observed associations between rush-
hour automobile commuting, in-vehicle exposures, and respiratory health outcomes are 
modified by one’s level of asthma control using a quasi-experimental study design to 
observe respiratory health outcomes before and after a 2-hour commute. Improving our 
understanding of the role of asthma control in modifying the impact of traffic exposures may 
provide valuable information about the susceptibility of adults with asthma, who commute 
by car during rush hour. Such improvements in our understanding of how asthma control 
affects susceptibility to adverse health effects of traffic-related exposures may have 
implications for the management of asthma, particularly for persons routinely exposed to 
traffic.
METHODS
Atlanta Commuter Exposure Study
We conducted an epidemiologic analysis using data collected for the ACE-1 pilot panel 
study.2,6
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The ACE-1 study was conducted between December 2009 and June 2011 when 21 adults 
with self-reported asthma and 21 adults without self-reported asthma used their private 
vehicles to drive a scripted 2-hour commute along heavily used commuting roadways in the 
metropolitan Atlanta area.6 The ACE-1 study protocol excluded a priori all potential study 
participants who reported the following: smoking, living in a home with a smoker, 
pregnancy, diabetes, previous myocardial infarction, implantable cardioverter-defibrillators 
or pacemakers, use of digoxin or beta blockers for treatment of hypertension or arrhythmias, 
or pulmonary disease other than asthma. We also excluded individuals with forced 
expiratory volume in 1 second (FEV1) lower than 70% of age-, race-, and sex-specific 
predicted FEV1,7 which was assessed using precommute spirometry. Participants were 
recruited largely by word of mouth and flyers posted on the Emory University and Centers 
for Disease Control and Prevention campuses.6 At the beginning of the study, all 
participants completed questionnaires to provide demographic and health-related 
information. Participants completed physical examinations pre- and postcommute. All 
commutes were conducted between 7:00 A.M. and 9:00 A.M. and began at the environmental 
health laboratory of the Rollins School of Public Health at Emory University. We excluded 
data from three participants who did not complete the questionnaire items used to categorize 
asthma control. Three participants withdrew from the study before completing the second 
study commute and the remaining 36 each completed two scripted commutes. Our final 
analyses were conducted using data collected from 39 participants and 75 commutes (Figure 
1). The ACE-1 study protocol and materials were approved by the Institutional Review 
Board of the Rollins School of Public Health at Emory University. Office of Management 
and Budget approval was obtained by the Centers for Disease Control and Prevention 
(Control No. 0920-0859). All participants provided written informed consent.
Traffic-related Exposures
As in previous analyses,6 traffic-related exposures were evaluated using two methods. First, 
we considered the entire 2-hour commute a complete exposure (i.e., “commute-as-exposure” 
models) and compared health measurements collected before the exposure (precommute) to 
those collected after the exposure (0, 1, 2, and 3 hours postcommute). Second, we assessed 
pollutant exposures during the commutes using 2-hour means of in-vehicle measurements of 
particulate matter ≤2.5 micrometers in diameter (PM2.5), particle number concentration, and 
the following PM2.5 components: elemental carbon, organic carbon, water-soluble organic 
carbon, particle-bound polycyclic aromatic hydrocarbons (PAHs), n-alkanes, and particulate 
iron (i.e., “pollutant-as-exposure” models). Pollutant data collection protocols, analytic 
methods, and data quality have been described in detail elsewhere.2,6 A previously 
published matrix of Pearson correlation coefficients indicating correlations of the in-vehicle 
particulate components6 also provides information about correlations in the data used for 
this analysis.
Respiratory Health Metrics
The concentration of exhaled NO in exhaled breath was measured using a portable NIOX 
MINO analyzer (Aerocrine, New Providence, NJ). The concentration of malondialdehyde in 
exhaled breath condensate was measured using high-performance liquid chromatography to 
assess the progression of airway lipid peroxidation reactions.6,8 Spirometry was conducted 
Mirabelli et al. Page 3













using OHD KoKo spirometers (Occupational Health Dynamics, Birmingham, AL). 
Spirometry measurements used in this analysis include FEV1, forced vital capacity (FVC), 
and forced expiratory flow between 25% and 75% of vital capacity (FEF25–75). Percentage 
of predicted values of FEV1, FVC, and FEF25–75 were calculated using standard reference 
equations published by Hankinson et al.7 We measured exhaled NO, malondialdehyde, and 
spirometry precommute, immediately postcommute, and 1, 2, and 3 hours after the commute 
using methods described previously.2,6
Level of Asthma Control
For participants with asthma, levels of asthma control were evaluated using the seven-item 
Asthma Control Questionnaire.9 The Asthma Control Questionnaire was adapted to collect 
information about experiences during the 3 months before data collection (e.g., “on average, 
during the past 3 months, how often were you woken by your asthma during the night?”). 
For six of the seven questionnaire items, respondents selected an answer along a seven-point 
scale that ranged from zero (e.g., “never”) to six (e.g., “unable to sleep because of asthma”). 
The seventh item was assigned using the percentage of predicted FEV1 values and a similar 
range of values from zero, for >95% predicted, to six, for <50% predicted.9 Percent of 
predicted FEV1 values were computed using spirometry performed before the first study 
commute. For each participant with asthma, Asthma Control Questionnaire scores were 
calculated as the mean of the values assigned to the seven individual questionnaire items.9 
Scores were then categorized as lower or higher than the median of the distribution of scores 
of the 18 participants with asthma (median: 0.79; mean: 1.09 [SD: 0.71]). Because lower 
Asthma Control Questionnaire scores convey better levels of asthma control, scores ≤0.79 
are hereafter referred to as “above-median asthma control” and scores >0.79 as “below-
median asthma control.”
Statistical Analysis
We conducted descriptive analyses to summarize the demographic characteristics of the 
study population, commutes completed, and in-vehicle pollutants measured during 
completed study commutes. To assess the relations between the rush-hour commute 
exposures and biomarkers of respiratory health, we used mixed effects linear regression with 
random-participant intercepts, which accounted for the correlations between data collected 
at multiple time points per participant.
For commute-as-exposure analyses in which the entire 2-hour commute is considered a 
complete exposure, we compared metrics of respiratory health measured after the commute 
(0, 1, 2, and 3 hours postcommute) to values measured precommute using separate models 
for each postcommute time point. In these models, each mixed effects linear regression 
model was specified with a random intercept for each participant and a spatial power 
covariance structure.10 The commute-as-exposure models that we used were variations of 
the generalized linear mixed model E(Y) = exp(α + Σβx) that modeled pre- and 
postcommute measurements of the respiratory health metric, precommute level of asthma 
control, and interaction terms to evaluate modification of the effect of the time point by level 
of asthma control, with no asthma considered the referent category. For models of the effect 
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of the commute on exhaled NO and malondialdehyde, we transformed concentrations using 
a natural log transformation, yielding a final model:
(1)
in which Yij is exhaled NO or malondialdehyde for individual i at time j, timeij is the 
postcommute indicator variable, score1i0 indicates above-median asthma control, score2i0 
indicates below-median asthma control, β0 is the fixed intercept term, and ui is the random 
intercept term ~N(0, σ2μ0). Associations generated using Equation 1 are presented as the 
percentage change in biomarker concentrations at each postcommute time point relative to 
precommute concentrations. Percentage changes were calculated as (exp(β1) − 1)·100 among 
individuals without asthma, (exp(β1 + β4) − 1) 100 among individuals with above-median 
asthma control, and ((exp(β1 + β5) − 1)·100 among individuals with below-median asthma 
control. Positive percentage changes in exhaled NO and malondialdehyde indicate adverse 
respiratory response among individuals with and without asthma. Associations generated 
using percentages of age-, race-, and sex-specific predicted spirometry values as dependent 
variables were based on similar models in which spirometry outcomes were not 
transformed:
(2)
For these models, associations are presented as mean changes in percent predicted values at 
each postcommute time point relative to precommute percent predicted values. Changes in 
percent predicted values were calculated as a linear combination of parameter estimates: ft 
among individuals without asthma, β1 + β4 among individuals with above-median asthma 
control, and β1 + β5 among individuals with below-median asthma control. For these results, 
negative changes in percent of predicted spirometry values indicate adverse respiratory 
response among individuals with and without asthma.
For pollutant-as-exposure analyses in which we evaluated effect of in-vehicle pollutant 
measurements, the mixed effects linear regression models were similarly specified with a 
random intercept for each participant and a spatial power covariance structure and 
interaction terms to evaluate modification of the effect of the in-vehicle pollutant exposures 
by level of asthma control. Estimates of the associations between each pollutant and 
respiratory health metric were generated using separate models for each postcommute time 
point and we estimated differences between post- and precommute measurements, 
controlling for precommute measurements, by adapting Equations 1 and 2 to the following, 
respectively:
(3)
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In equations 3 and 4, Δln(Yij) and Δ(Yij) represent the differences between measurements at 
post- and precommute time points (i.e., ln(Yij) - ln(Yi0) and Yij - Yi0 respectively). 
Associations are presented as the percentage change in biomarkers of inflammation or 
changes in the percent predicted at each postcommute time point associated with an 
interquartile range increase in pollutant concentration. For all commute-as-exposure and 
pollutant-as-exposure models, we evaluated the contributions of the interaction terms to the 
fit of the model to the data by contasting −2 Log Likelihood values of the models described 
above to those of models from which the two interaction terms were excluded. P values for 
interaction (Pint) <0.10 are presented.
Following our main analyses, we conducted sensitivity analyses to evaluate the impact on 
our results of our decision to dichotomize the distribution of Asthma Control Questionnaire 
scores at 0.79, the median score in our study population and therefore a cut-point that 
optimized the distribution of the observations in our study. These sensitivity analyses were 
conducted using identical models as those described above and an Asthma Control 
Questionnaire score cut-point of 1.00, where scores ≤1.00 were categorized as “well-
controlled” and >1.00 were categorized as “not well-controlled.”11 For this sensitivity 
analysis, we selected the cut-point of 1.00 on the basis of a crossover point between well-
controlled and not well-controlled reported by Juniper et al.11 All analyses were performed 
using SAS version 9.3 (SAS Institute Inc., Cary, NC), and results are presented with 95% 
confidence intervals (CIs).
RESULTS
Characteristics of the 39 ACE-1 study participants included in our analysis are shown in 
Table 1 for participants without asthma and, for participants with asthma, by level of asthma 
control. Participants without asthma were older (mean: 35 years) than participants with 
above- (mean: 35 years) or below- (mean: 31 years) median asthma control. Participants’ 
Asthma Control Questionnaire scores ranged from 0.29 to 0.71 among individuals 
categorized as having above-median level asthma control and from 0.86 to 2.43 among those 
categorized as having below-median asthma control (Table 2). Measured precommute, 
exhaled NO concentrations were lower among participants without asthma (mean [SD]: 22.7 
[12.4] ppb) than those with asthma (mean [SD]: 43.2 [37.8] ppb, data not shown). Mean 
precommute malondialdehyde concentrations were also lower among participants without 
asthma (0.08 [SD: 0.03] μmol·L−1) than participants with asthma (0.12 [SD: 0.07] μmol·L−1, 
data not shown). Mean values of the spirometry measures were higher among participants 
with above-median levels of asthma control than those with below-median asthma control or 
without asthma.
Table 3 shows concentrations of PM2.5 and its components measured inside participants’ 
vehicles during the study commutes. Mean concentrations of PM2.5, elemental carbon, 
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organic carbon, and particle-bound PAH were higher in vehicles driven by participants 
without asthma than in vehicles driven by participants with asthma; for these five pollutants, 
differences between the groups ranged from 18% higher for particle-bound PAH to 94% 
higher for elemental carbon. As described previously,6 the observed differences in pollutant 
concentrations measured in vehicles driven by participants with and participants without 
asthma are believed to be random with respect to with the recruitment of participants and 
participant asthma status. Additional description of the concentrations of these in-vehicle 
pollutants have been published previously.2
Results of commute-as-exposure models in which we evaluated postcommute changes in 
exhaled NO, malondial-dehyde and percents of predicted FEV1, FVC, and FEF25–75 values 
are shown in Figure 2. Relative to precommute measurements, exhaled NO concentrations 
were higher at all postcommute time points. The largest postcommute increases in exhaled 
NO were observed among participants with below-median asthma control (0 hour: 9.1% 
[95% Cl = 2.1, 16.6]; 1 hour: 17.9% [95% Cl = 8.9, 27.7]; 2 hours: 14.6% [95% Cl = 5.7, 
24.2]; 3 hours: 19.5 [95% Cl = 7.8, 32.5]). We observed no postcommute changes in 
malondialdehyde. Postcommute FEV1 % predicted and FEF25–75 % predicted were slightly 
elevated relative to precommute measurements, particularly among participants with below-
median asthma control.
Associations between in-vehicle pollutant concentrations and exhaled NO concentrations 
measured pre- versus postcommute were generally stronger among individuals with below-
median asthma control than among individuals without asthma or with above-median 
asthma control (Figure 3). Among respondents with below-median asthma control, an 
increase in PM2.5 equal to the interquartile range of in-vehicle measurements was associated 
with a 22.6% (95% Cl = 5.5, 42.4) increase in exhaled NO measured 3 hours postcommute. 
Despite imprecision in estimates of the percent changes in malondialdehyde associated with 
in-vehicle pollutant measurements, we observed differences across asthma control 
categories at postcommute time points; these results are available in Online Supplement 
Figure S1 (http://links.lww.com/EDE/A906).
Pollutant-as-exposure models in which changes in FEV1 % predicted were regressed on in-
vehicle pollutant concentrations are shown in Figure 4. In contrast to the commute-as-
exposure results, interquartile range increases in pollutant concentrations and FEV1 % 
predicted were not consistently associated with elevations in FEV1 % predicted 3 hours 
postcommute. Although the estimates were imprecise and largely consistent with the null, 
higher PM2.5 levels were associated with declines in FEV1 % predicted, particularly at the 2- 
and 3-hour-postcommute time points and among participants with above-median asthma 
control (2 hours: −0.8% [95% CI = −4.8, 3.2]; 3 hours: −3.1 [95% CI = −8.3, 2.1]) and 
below-median asthma control (2 hours: −3.1% [95% CI = 6.8, 0.6]; 3 hours: −7.2 [95% CI = 
−11.8, −2.7]). Estimates of the associations of in-vehicle pollutant measurements with 
changes in FVc % predicted and FEF25–75 % predicted are available in Online Supplement 
Figures S2 and S3, respectively (http://links.lww.com/EDE/A906). Overall, estimates of 
these associations were imprecise, although greater decrements in lung function were 
generally observed among participant with below-median levels of asthma control than 
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participants with above-median asthma control or no asthma, and the observed differences 
generally increased with increasing time after the study commute.
Our sensitivity analyses, designed to evaluate the impact of changing the cut-point used to 
categorize Asthma Control Questionnaire scores from 0.79 to 1.00, resulted in a 
reclassification of two people and a final categorization of 21 individuals without asthma, 11 
with well-controlled asthma, and seven with asthma not well controlled. Overall, estimates 
generated in these analyses were similar in magnitude and direction to those generated in 
our main analyses, though recategorization affected the precision of the estimates (data not 
shown).
DISCUSSION
Using data from the ACE-1 study, we examined asthma control as a potential modifier of 
the associations between exposures measured in personal passenger vehicles during morning 
rush-hour commutes and changes in exhaled NO, malondialdehyde, and three spirometric 
measures of pulmonary function. Despite the small number of participants in our study, 
these results identify variation in the associations between commuting and shortterm 
respiratory response by the presence of asthma and, among those with asthma, by level of 
asthma control and provide initial evidence about the influence that asthma control may 
have on susceptibility to adverse respiratory health outcomes after traffic-related exposures 
experienced during typical morning rush-hour commutes. Results of analyses of in-vehicle 
pollutant components as exposures further suggest that postcommute responses may be 
triggered by specific in-vehicle pollutant exposures. Estimated changes in spirometry 
generated from our pollutant-as-exposure models are notable for their contrasts with 
estimates of changes in spirometry when we examined the commute as a complete exposure, 
which did not indicate pre- to postcommute declines in FEVP FVC, or FEF25–75. However, 
for several pollutants, decrements in these lung function metrics were observed at higher 
levels of in-vehicle pollutants (e.g., PM2.5), with the observed decrements largely driven by 
response among individuals with below-median asthma control. In our previous analysis in 
which asthma control was not considered, we did not observe pollutant-specific associations 
with lung function.6 In this analysis, although no single pollutant was consistently associated 
with changes in our selected respiratory health outcomes, several ubiquitous particulate 
components were associated with measurable responses in one or more of the end points. 
For panel studies such as ours, this is not uncommon; and neither our study nor the few 
other published studies that have used similar research designs have conclusively identified 
a single causal pollutant or class of pollutants.12,13 Nonetheless, findings from the AcE-1 
study extend our initial observations about the role of specific chemical pollutants in 
eliciting respiratory response6 and our current understanding of the potential respiratory 
health impacts of traffic-related air pollutants3,4,12 by highlighting the potential influence of 
asthma control on individual-level susceptibility
Short-term response to air pollution has been investigated in previous epidemiologic studies, 
including a study of respiratory response after 2-hour walks along a busy London street 
(Oxford Street) and through nearby Hyde Park,12 a study of health effects after a 2-hour car 
ride in which investigators reported modification of the effect of the highway exposure on 
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endothelial derived No by diabetic status,14 and an evaluation of associations between urban 
air quality and weekly Asthma control Questionnaire scores among 36 school-age children 
that reported a suggestion of positive associations between PM2.5 and asthma control 
Questionnaire score.15 after an evaluation of exhaled NO response among school children 
affected by air pollution before and during the 2008 Olympics in Beijing, Lin et al.16 
reported robust associations between PM2.5 and exhaled NO, which were, broadly speaking, 
modestly stronger among children with asthma than among children without asthma. From a 
case-crossover study in which participants completed 2-hour walks along the heavily 
trafficked Oxford Street and in Hyde Park, London, McCreanor et al.12 reported larger 
respiratory responses after the Oxford Street route than after the Hyde Park route and among 
participants with moderate asthma than among those with mild asthma; such differences in 
respiratory response were observed up to 7 hours after the start of the exposure and, in some 
cases, even 22 hours after the start of the exposure. In contrast, the follow-up in our study 
was limited to 3 hours postcommute and therefore cannot be used to draw conclusions about 
the role of asthma control in observed respiratory health effects of longer duration. Despite 
this limitation, our findings contribute to a growing body of literature about the role of 
individual-level susceptibility to ambient air quality exposures.
The effects of exposure to ambient air pollution, including to traffic-related air pollution, on 
the airways are well documented to include changes in biomarkers of oxidative stress and 
inflammation and decrements in lung function.17-21 Our finding of elevated exhaled NO 
concentrations at all postcommute time points and variation across levels of asthma control 
support the hypothesis that acute inflammatory response may be modified by asthma 
control. Results from our pollutant-as-exposure models further suggest that the 
inflammatory response, including variation by level of asthma control, may be differentially 
affected by specific particulate components. In contrast, our results do not support this 
hypothesis for malondialdehyde, a biomarker of oxidative stress, and results for spirometric 
measurements are inconsistent. Evaluated in total, differences between effects generated 
using commute-as-exposure models and pollutant-as-exposure models may suggest that 
individual particulate components may not affect the same biologic pathways to respiratory 
response. Indeed, although individual commuters have little control over the outdoor air 
quality and particulate components present during morning rush hour, evidence that asthma 
control may affect individual susceptibility may provide commuters who have asthma and 
their health care providers an opportunity to lessen the extent to which their asthma may be 
exacerbated by their daily activities.
In this analysis, we used mixed-effects linear regression models to account for correlations 
in outcomes measured in the same individuals over time and in other unmeasured, 
individual-level characteristics. Our ability to construct similar models for these analyses as 
those developed by Sarnat et al.6 is a notable strength of our analysis. Our study population 
included 18 participants with asthma and 21 participants without asthma, 17 and 19 of 
whom, respectively, completed two study commutes each. Despite measurements provided 
by each participant at up to 10 time points, the relatively small number of observations in 
our analysis, and missing data for several measures limit our ability to conduct additional 
analysis to explore the roles of body mass index, medication use, general health status, 
automobile characteristics, in-vehicle ventilation, temperature, humidity, rainfall, season, 
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multipollutant exposures or other factors that may influence susceptibility to in-vehicle air 
pollutants.3 additional information about these and other factors may further improve our 
ability to draw conclusions about the extent to which relations between commuting-related 
exposures and respiratory health outcomes are modified by individual-level and 
environmental factors. In particular, additional information about the types and frequencies 
of medications used by individuals with asthma may improve our understanding of how 
asthma medications affect individual-level susceptibility to traffic-related exposures. The 
small size of our study precluded evaluation of the extent to which the effect modification 
observed in our study may have been driven by individual components or clusters of 
components of the seven-item asthma control Questionnaire. Despite the lack of information 
about medication use, the small number of observations in the ACE-1 study, and the limited 
statistical power to detect exposure–outcome associations, the associations generated by our 
analysis suggest effect measure modification by level of asthma control. The extent to which 
demographic, socioeconomic, health, and other characteristics of the ACE-1 study 
population differ from those of the general population limits our ability to generalize our 
findings to populations external to the ACE-1 cohort.
Individual-level characteristics, including asthma status and six of the seven components of 
the Asthma Control Questionnaire, were self-reported by study participants at the beginning 
of the study. If participants experienced changes in their asthma status, symptoms, or level 
of control between the time of enrolling in the study and the time of completing the second 
study commute, our results may not reflect the true extent to which level of asthma control 
affects susceptibility to commute-related exposures. Despite including FEV1 % predicted as 
one element of the Asthma control Questionnaire, our analyses included evaluation of the 
effect of commute-related exposures on FEV1 % predicted as an independent variable. 
Because the Asthma control Questionnaire and spirometry data were collected before each 
participant’s first commute, the FEV1 component of the Asthma Control Questionnaire and 
the spirometry outcomes in our analysis are correlated (e.g., Pearson correlation coefficient 
for correlation between Asthma control Questionnaire score and FEV1 % predicted = −0.43; 
P = 0.08). In our commute-as-exposure analyses, we evaluated changes in lung function 
relative to precommute measurements to minimize the impact of precommute measures on 
our results. In these models, lower precommute measures of spirometry in the group with 
below-median asthma control could plausibly limit the magnitude of potential postcommute 
declines in each of the three lung function measurements. In fact, our commute-as-exposure 
models generated estimated increases in postcommute FEV1 and FEF25–75 among 
participants with below-median asthma control. The interpretation of these improvements as 
an indicator that participants’ abilities to perform forced exhalation maneuvers may improve 
over time is not supported by previous research designed to evaluate learning effects and 
variation in spirometry among healthy adults.22 The objective measures of respiratory health 
measured in the AcE-1 study strengthen the interpretation of our findings.
As noted previously,6 pollutant concentrations varied across the three asthma control 
categories. For six of the eight PM2.5 components included in our analysis, mean and 
median concentrations were higher during commutes completed by individuals without 
asthma. If the relation between the measured pollutants and metrics of respiratory health 
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evaluated in our study is not linear, but instead has a threshold level of effect, for example, 
then the differences in pollutant concentrations during commutes completed by participants 
without asthma and those present during commutes completed by the remaining participants 
may have meaningfully affected our findings. In such a scenario, the observed exposure 
differences may result in an underestimation of the true differences between the exposure–
outcome relations of participants with asthma and those without asthma. The lack of days 
without in-vehicle exposures with which to compare our data is a notable limitation. 
However, the relatively large number of distinct study commutes (n = 75) is a strength of 
our study.
Overall, and in combination with previous findings,6 these results extend our understanding 
of the effect of traffic-related exposures on respiratory health by evaluating potential short-
term and adverse impacts on metrics of respiratory health. These findings may be of interest 
to health care providers, public health personnel, commuters, and others interested in 
attenuating adverse health effects experienced by individuals with asthma.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Selection of the final ACE-1 study population for analysis.
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Change (with 95% CI) in exhaled NO, malondialde-hyde, FEV1 % predicted, FVC % 
predicted, and FEF25–75 % predicted among ACE-1 study participants. Postcommute 
changes shown are relative to precommute concentrations among participants without 
asthma (white diamond), above-median asthma control (gray diamond), and below-median 
asthma control (black diamond). Asterisks P value for interaction (Pint) <0.10.
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Percentage change (with 95% CI) in exhaled NO concentration associated with each 
interquartile range increase in pollutant concentration among participants without asthma 
(white diamond), above-median asthma control (gray diamond), and below-median asthma 
control (black diamond). Asterisks P value for interaction (Pint) <0.10.
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Change (with 95% CI) in FEV1 % predicted values associated with each interquartile range 
increase in pollutant concentration, by level of asthma control. Postcommute changes in 
FEV1 % predicted shown are percentage points above or below precommute % predicted 
values among participants without asthma (white diamond), above-median asthma control 
(gray diamond), and below-median asthma control (black diamond). Asterisks P value for 
interaction (Pint) <0.10.
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TABLE 1
Characteristics of the ACE-1 Study Population (N = 39) and Completed Study Commutes (N = 75)
Level of Asthma Control
















  White 13 (62) 5 (56) 5 (56)
  Not white 8 (38) 4 (44) 4 (44)
 Sex
  Female 8 (38) 3 (33) 8 (89)
  Male 13 (62) 6 (67) 1 (11)
Commute characteristics
 Total commutes completed
  1 2 (10) 0 (0) 1 (11)
  2 19 (90) 9 (100) 8 (89)
 Date ranges of commutes
  1st commute Dec 2009–Apr 2011 May 2010–Mar 2011 Oct 2010–Apr 2011
  2nd commute Apr 2010–Jun 2011 Mar 2011–Jun 2011 Apr 2011–May 2011
 Interval between commutes
c,d
  Mean (SD) 24.8 (16.9) 21.7 (15.1) 14.3 (8.5)
  Median 19 17 13
a






Among participants who completed two commutes.
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TABLE 2
Indicators of Respiratory Health Measured Before the First ACE-1 Study Commute










 No. observations 9 9
 Mean (SD) 0.51 (0.05) 1.68 (0.17)
 Minimum, maximum 0.29, 0.71 0.86, 2.43
Exhaled NO (ppb)
 No. observations 21 9 9
 Mean (SD) 22.7 (12.4) 36.4 (22.3) 49.9 (49.4)
 Median 20.0 30.0 29.0
Malondialdehyde (μmol·l−1)
 No. observations 16 8 9
 Mean (SD) 0.08 (0.03) 0.13 (0.08) 0.11 (0.06)
 Median 0.07 0.10 0.10
FEV1, % predicted
 No. observations 20 9 9
 Mean (SD) 101.5 (14.0) 108.1 (13.8) 93.1 (15.2)
 Median 98.9 112.9 90.1
FVC, % predicted
 No. observations 20 9 9
 Mean (SD) 101.2 (17.0) 108.6 (8.3) 103.4 (13.1)
 Median 99.9 108.1 101.6
FEF25–75, % predicted
 No. observations 20 9 9
 Mean (SD) 101.9 (19.0) 112.7 (35.5) 78.6 (31.5)
 Median 104.9 108.4 69.2
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TABLE 3
In-vehicle Air Pollutant Measurements Collected During Rush-hour Automobile Commutes Completed by 
ACE-1 Study Participants











No. eligible commutes 39 18 17
PM2.5 (μg·m−3)
 No. commutes measured 36 18 17
 Mean (SD) 28.8 (14.4) 23.8 (11.7) 21.0 (12.8)
 Median 27.5 21.5 18.9
 Interquartile range 20.9 20.9 13.1
Particle number concentration a
 (No. particles per cm3)
 No. commutes measured 36 18 16
 Mean (SD) 28.4 (14.4) 26.3 (6.9) 21.5 (11.1)
 Median 27.3 25.0 20.5
 Interquartile range 19.5 7.2 17.8
Elemental carbonb (μg·m−3)
 No. commutes measured 39 18 13
 Mean (SD) 3.5 (2.0) 2.0 (1.4) 1.6 (0.9)
 Median 3.2 1.7 1.4




 No. commutes measured 38 18 13
 Mean (SD) 22.0 (6.5) 16.0 (7.4) 15.7 (5.1)
 Median 21.0 16.1 13.8
 Interquartile range 9.0 7.6 4.6
Water-soluble organic carbon
 (μg-m−3)
 No. commutes measured 35 18 13
 Mean (SD) 6.5 (3.1) 5.5 (5.7) 6.7 (3.9)
 Median 6.7 4.6 6.3
 Interquartile range 2.9 3.2 2.5
Particle-bound PAHs (ng·m−3)
 No. commutes measured 39 18 15
 Mean (SD) 128.1 (33.8) 118.2 (34.5) 97.1 (17.8)
 Median 128.0 103.9 96.1




 No. commutes measured 37 15 11
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 Mean (SD) 49.2 (34.5) 117.4 (316.5) 37.5 (25.6)
 Median 40.9 32.2 34.8
 Interquartile range 23.0 46.7 17.3
Iron (ng·m−3)
 No. commutes measured 38 18 13
 Mean (SD) 310.6 (224.1) 176.7 (115.0) 225.5 (356.4)
 Median 273.0 178.4 136.0




Elemental and organic carbons measured using filter-based thermal-optical transmittance.
c
Sum of n-Alkanes with 23–27 carbons.
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